We have synthesized quinolinones with potential antiparasitic and anti-HIV activities by an original two-step method involving microwave irradiation and have evaluated their activities against Plasmodium falciparum, Leishmania donovani, Trichomonas vaginalis, and HIV. None of the tested compounds had been previously described using this method of synthesis. One of the compounds had interesting antiparasitic
Gas-phase pyrolysis of aminomethylene Meldrum’s acidderivatives gave quinolinones and/or amines depending on the -nature of arylamino moiety. Effect of substituent on reaction rate and nature of pyrolysis products supports the suggested intramolecular nucleophilic substitution reaction via initially formed keteneamine intermediate.
Assembly of 4-Aminoquinolines via Palladium Catalysis: A Mild and Convenient Alternative to S<sub>N</sub>Ar Methodology
作者:Brandon J. Margolis、Kimberly A. Long、Dana L. T. Laird、J. Craig Ruble、Shon R. Pulley
DOI:10.1021/jo062168u
日期:2007.3.1
4-Aminoquinolines, classically prepared via SNAr chemistry from an amine and 4-haloquinoline, are important scaffolds in medicinal chemistry. Interest in these compounds prompted us to explore palladium catalysis as an alternative to the existing methods for their preparation. Initial results followed by an iterative screening paradigm confirmed Pd(OAc)(2)/ DPEphos/K3PO4 as a mild and convenient alternative for the formation of the C-N bond in 4-aminoquinolines. A description of the screen and the scope of this methodology are discussed herein.
Synthesis and pharmacological evaluation of new cysLT1 receptor antagonists
This paper describes the synthesis and pharmacological evaluation of three series of compounds 4a-b, 13a-k and 19, structurally related to the known potent cysLT(1) receptor antagonists RG-12553, ICI-204219 and ONO-1078, respectively. The common structural feature of these new series is the presence of a 4-quinolone nucleus acting as a template for substitution of the aromatic nucleus present in the prototype antagonists. We describe the evolution of these series leading to antagonists with potency at nanomolar concentrations in vitro.
Wetzel et al., Journal of the American Pharmaceutical Association (1912), 1946, vol. 35, p. 331,332